NP Life Sciences Health Industry Group Inc. (ACAT) › Cash & EquivalentsNP Life Sciences Health Industry Group Inc. (ACAT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $2002019: $242.9K2020: $118.6K2021: $28.0K2022: $121.9K2023: $70.6K$70.6K2018Cash & Equivalents (USD)2023Fiscal YearCash & EquivalentsChange YoY2023$70.6K-42.1%2022$121.9K+335.4%2021$28.0K-76.4%2020$118.6K-51.2%2019$242.9K+121366.5%2018$200—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share